Compare · OHI vs VTR
OHI vs VTR
Side-by-side comparison of Omega Healthcare Investors Inc. (OHI) and Ventas Inc. (VTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OHI and VTR operate in Real Estate Investment Trusts (Real Estate), so they compete in similar markets.
- VTR is the larger of the two at $44.87B, about 3.1x OHI ($14.28B).
- Over the past year, OHI is up 31.3% and VTR is up 45.1% - VTR leads by 13.8 points.
- OHI has been more active in the news (8 items in the past 4 weeks vs 7 for VTR).
- Both have 25 recent analyst ratings on file.
- Company
- Omega Healthcare Investors Inc.
- Ventas Inc.
- Price
- $49.87+4.05%
- $95.03+3.00%
- Market cap
- $14.28B
- $44.87B
- 1M return
- +10.30%
- +13.86%
- 1Y return
- +31.32%
- +45.08%
- Industry
- Real Estate Investment Trusts
- Real Estate Investment Trusts
- Exchange
- NYSE
- NYSE
- IPO
- 1992
- News (4w)
- 8
- 7
- Recent ratings
- 25
- 25
Omega Healthcare Investors Inc.
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Ventas Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Latest OHI
- Barclays initiated coverage on Omega Health with a new price target
- Omega Announces Second Quarter Earnings Release Date and Conference Call
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Stephenson Robert O
- SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Pickett C Taylor
- SEC Form 4 filed by CHIEF LEGAL OFFICER Makode Gail D
- CHIEF ACCOUNTING OFFICER Ballew Neal was granted 168 shares and returned $524 worth of shares to the company (11 units at $47.68), increasing direct ownership by 3% to 4,665 units (SEC Form 4) (tax withholding)
- SEC Form 4 filed by President Gourmand Matthew Paul
- SEC Form 4 filed by Chief Investment Officer Gupta Vikas
- Raymond James resumed coverage on Omega Health with a new price target
- SEC Form 4 filed by Director Plavin Stephen D
Latest VTR
- Barclays initiated coverage on Ventas with a new price target
- Director Smith Maurice S was granted 461 shares, increasing direct ownership by 2% to 31,184 units (SEC Form 4)
- Director Roy Sumit was granted 349 shares, increasing direct ownership by 1% to 24,753 units (SEC Form 4)
- Director Martino Roxanne M was granted 544 shares, increasing direct ownership by 0.82% to 66,672 units (SEC Form 4)
- Director Lustig Matthew J was granted 448 shares, increasing direct ownership by 0.47% to 95,453 units (SEC Form 4)
- Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call
- Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research
- Raymond James resumed coverage on Ventas with a new price target
- Ventas Inc. filed SEC Form 8-K: Leadership Update, Other Events
- Director Embler Michael J bought $197,025 worth of shares (2,500 units at $78.81), increasing direct ownership by 15% to 19,202 units (SEC Form 4)